MedPath

Metabolic Effects of a Thermogenic Ready-to-drink Beverage

Not Applicable
Completed
Conditions
Metabolic Rate
Metabolism
Interventions
Other: Thermogenic Ready-to-drink Beverage
Other: Placebo Ready-to-drink Beverage
Registration Number
NCT05194475
Lead Sponsor
Texas Tech University
Brief Summary

This study is a randomized, double-blind, placebo-controlled crossover trial examining the metabolic effects of a novel ready-to-drink (RTD) beverage. Healthy adult males and females will be recruited for participation. Each participant will complete two conditions in random order: 1) RTD thermogenic beverage ; and 2) placebo (consisting of the flavoring of the thermogenic beverage without the active ingredients). In each condition, metabolism (resting metabolic rate), hemodynamic (heart rate and blood pressure), and subjective (ratings of energy, focus, concentration, alertness, and mood) assessments will be completed at baseline, 30 minutes after beverage consumption, and 30 minutes after the second round of assessments.

Detailed Description

The primary purpose of this study is to report the metabolic effects of a new ready-to-drink (RTD) version of EHP Labs OxyShred Thermogenic Fat Burner. Additionally, the effect of this product on hemodynamic variables and subjective ratings of energy, focus, concentration, alertness, and mood will be reported.

OxyShred Thermogenic Fat Burner (EHP Labs) is a popular dietary supplement for those seeking to increase energy and reduce body fat. While this product is commercially available as a powdered dietary supplement, a new RTD formulation is currently being developed. While the RTD formula will be similar to the current version of the product, research specifically conducted with the RTD version is needed to definitively support product claims and demonstrate the potential effects of this novel product. Additionally, there is a need to better understand the effects of caffeine-containing, thermogenic products among the variety of groups who may consume these products (e.g., males vs. females, inactive vs. active, etc.).

This study is a randomized, double-blind, placebo-controlled crossover trial examining the metabolic effects of a novel ready-to-drink (RTD) beverage. Healthy adult males and females will be recruited for participation. Each participant will complete two conditions in random order: 1) RTD thermogenic beverage ; and 2) placebo (consisting of the flavoring of the thermogenic beverage without the active ingredients). In each condition, metabolism (resting metabolic rate), hemodynamic (heart rate and blood pressure), and subjective (ratings of energy, focus, concentration, alertness, and mood) assessments will be completed at baseline, 30 minutes after beverage consumption, and 30 minutes after the second round of assessments.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
28
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Thermogenic Ready-to-drink BeverageThermogenic Ready-to-drink BeverageArm in which a thermogenic ready-to-drink beverage is ingested.
Placebo Ready-to-drink BeveragePlacebo Ready-to-drink BeverageArm in which a placebo ready-to-drink beverage is ingested.
Primary Outcome Measures
NameTimeMethod
Resting metabolic rate140 minutes

Resting metabolic rate from indirect calorimetry expressed as kilocalories expended per unit time (e.g., kcal/min).

Respiratory quotient140 minutes

Respiratory quotient from indirect calorimetry in arbitrary units, which reflects the proportion of carbohydrate and fat oxidized at rest.

Secondary Outcome Measures
NameTimeMethod
Subjective rating of energy140 minutes

Subjective rating of energy as assessed by visual analog scale.

Subjective rating of focus140 minutes

Subjective rating of focus as assessed by visual analog scale.

Heart rate140 minutes

Heart rate from automated sphygmomanometer expressed in beats per minute.

Subjective rating of concentration140 minutes

Subjective rating of concentration as assessed by visual analog scale.

Subjective rating of alertness140 minutes

Subjective rating of alertness as assessed by visual analog scale.

Subjective rating of mood140 minutes

Subjective rating of mood as assessed by visual analog scale.

Systolic blood pressure140 minutes

Systolic blood pressure from automated sphygmomanometer expressed in beats per minute.

Diastolic blood pressure140 minutes

Diastolic blood pressure from automated sphygmomanometer expressed in beats per minute.

Trial Locations

Locations (1)

Department of Kinesiology & Sport Management

🇺🇸

Lubbock, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath